Metabolic syndrome is a clustering of abnormalities that includes obesity, hyperglycemia, high blood pressure, and atherogenic dyslipidemia. Advances in scientific knowledge, the increasing prevalence of obesity, and the disorder's role in contributing to cardiovascular disease and diabetes are fueling interest in metabolic syndrome.
McMaster University researchers have developed a precise and reliable blood test to monitor the intake of fats by individuals. This blood test may serve as a tool to guide public health policy related to healthy eating.
Researchers in Pennsylvania and Texas have discovered a novel protein sensor that limits the amounts of fat and sugar that are converted into energy by human cells, during the starvation periods.
Researchers have confirmed that Orujo olive oil produces a significant reduction in obesity and inflammatory complications in obese mice.
Researchers have successfully identified novel compounds to prolong the period of the circadian clock and have also explained their mechanisms of action.
An animal study has found that obese females who consumed a small amount of coconut oil every day, in spite of having a high-fat diet, exhibited reduced metabolic syndrome—several risk factors that increase the possibilities of developing heart disease, diabetes, and stroke.
Scientists have established a lipidomic method that proved successful in the analysis of human subcutaneous adipose biopsies.